NAMPT and type 2 diabetes mellitus: Surprisingly, this work could not find a positive correlation between visfatin levels in type 2 diabetic patients and asymmetric dimethylarginine (ADMA), the major endogenous inhibitor of the endothelial nitric oxide synthase (eNOS) [33].